Morning Briefing
Summaries of health policy coverage from major news organizations
GlaxoSmithKline To Cut Some Drug Costs In Emerging Markets
GlaxoSmithKline (GSK) plans to decrease the prices of many of its leading medicines in emerging markets following the success of a pilot program in the Philippines, Andrew Witty, GSK's chief executive, said, Financial Times reports.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
